Status
Conditions
About
a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome of ICSI- antagonist cycles
Full description
a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome (oocyte quality, fertilization rate, implantation rate, clinical pregnancy rate as well as the incidence of OHSS) in ICSI- antagonist cycles
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
600 participants in 3 patient groups
Loading...
Central trial contact
Kamal eldin Rageh, M.D.; Ahmed Barakat, FRCOG
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal